{"DataElement":{"publicId":"6986562","version":"1","preferredName":"Data Set Precancerous Condition MCL Type","preferredDefinition":"The classification of pre-cancerous cells found in a specific data set being study by the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions (MCL).","longName":"6983217v1.0:6863672v2.0","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6983217","version":"1","preferredName":"Data Set Precancerous Condition","preferredDefinition":"A collection of related data records._A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","longName":"2494295v1.0:6815742v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2494295","version":"1","preferredName":"Data Set","preferredDefinition":"A collection of related data records.","longName":"C47824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Data Set","conceptCode":"C47824","definition":"A collection of related data records.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B084C9-D1EB-08D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-03","modifiedBy":"ONEDATA","dateModified":"2006-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6815742","version":"1","preferredName":"Precancerous Condition","preferredDefinition":"Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)","longName":"C3341","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Precancerous Condition","conceptCode":"C3341","definition":"A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D557870-F56F-1FF4-E053-F662850AE697","latestVersionIndicator":"Yes","beginDate":"2019-07-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-10","modifiedBy":"ONEDATA","dateModified":"2019-07-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E44C73-D46E-66F4-E053-F662850A2552","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeDescription":"3/22/22 jk LabCas AI, released as part of quarterly draft content review and prior reviews with SME.  10/14/19 jk created for LabCas PCA-Genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6863672","version":"2","preferredName":"MCL Precancerous Condition Type","preferredDefinition":"A consortium consisting of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers._A pathological process with signs indicating it may become cancerous. Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia._Something distinguishable as an identifiable class based on common qualities.","longName":"6863672v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F09-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"Lobular carcinoma in situ (LCIS)","valueDescription":"Lobular Carcinoma In Situ","ValueMeaning":{"publicId":"3251341","version":"1","preferredName":"Lobular Carcinoma In Situ","longName":"3251341","preferredDefinition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-9DB9-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F13-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"DCIS-Comedo","valueDescription":"Breast Ductal Carcinoma In Situ, Comedo Type","ValueMeaning":{"publicId":"7848455","version":"1","preferredName":"Breast Ductal Carcinoma In Situ, Comedo Type","longName":"7848455","preferredDefinition":"Breast ductal carcinoma in situ characterized by the presence of sheets of tumor cells with evidence of central necrosis and associated karyorrhectic/nuclear debris.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Comedo Type","conceptCode":"C176005","definition":"Breast ductal carcinoma in situ characterized by the presence of sheets of tumor cells with evidence of central necrosis and associated karyorrhectic/nuclear debris.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D27C0B0F-308C-3583-E053-4EBD850A7622","latestVersionIndicator":"Yes","beginDate":"2021-12-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-12-06","modifiedBy":"ONEDATA","dateModified":"2021-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F1E-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"DCIS-Papillary","valueDescription":"Papillary Ductal Breast Hyperplasia","ValueMeaning":{"publicId":"6650901","version":"1","preferredName":"Papillary Ductal Breast Hyperplasia","longName":"6650901","preferredDefinition":"Benign papillary proliferation within the ductal system of the breast parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Papillary Ductal Hyperplasia","conceptCode":"C5200","definition":"Benign papillary proliferation within the ductal system of the breast parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82537DCF-C136-6679-E053-F662850ADFFD","latestVersionIndicator":"Yes","beginDate":"2019-02-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-02-20","modifiedBy":"ONEDATA","dateModified":"2019-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F29-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"DCIS-Micropapillary","valueDescription":"Intraductal Micropapillary Breast Carcinoma","ValueMeaning":{"publicId":"3249012","version":"1","preferredName":"Intraductal Micropapillary Breast Carcinoma","longName":"3249012","preferredDefinition":"An intraductal papillary carcinoma in which the neoplastic epithelial cells are arranged in micropapillary patterns.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Micropapillary Ductal Carcinoma In Situ","conceptCode":"C5139","definition":"Breast ductal carcinoma in situ characterized by the presence of neoplastic epithelial cells arranged in micropapillary patterns.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-157C-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F34-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"DCIS-Cribriform","valueDescription":"Intraductal Cribriform Breast Adenocarcinoma","ValueMeaning":{"publicId":"3249020","version":"1","preferredName":"Intraductal Cribriform Breast Adenocarcinoma","longName":"3249020","preferredDefinition":"A ductal carcinoma in situ of the breast characterized by the presence of a cribriform architectural pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ, Cribriform Pattern","conceptCode":"C5138","definition":"Breast ductal carcinoma in situ characterized by the presence of a cribriform architectural pattern.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6CA5E9E-1614-D7DA-E040-BB89AD432E47","latestVersionIndicator":"Yes","beginDate":"2011-06-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F49-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"DCIS-Solid (mosaic, microanicar)","valueDescription":"Mosaic Ductal Breast Carcinoma In Situ, Solid Type","ValueMeaning":{"publicId":"6650903","version":"1","preferredName":"Mosaic Ductal Breast Carcinoma In Situ, Solid Type","longName":"6650903","preferredDefinition":"An individual containing two or more populations of genetically different cells that arose from a single zygote.: A ductal carcinoma in situ of the breast in which the tumor cells fill the ductal spaces as solid sheets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mosaic","conceptCode":"C88144","definition":"An individual containing two or more populations of genetically different cells that arose from a single zygote.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Ductal Carcinoma In Situ, Solid Type","conceptCode":"C66933","definition":"Breast ductal carcinoma in situ in which the tumor cells fill the ductal spaces as solid sheets.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82537DCF-C187-6679-E053-F662850ADFFD","latestVersionIndicator":"Yes","beginDate":"2019-02-20","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-02-20","modifiedBy":"ONEDATA","dateModified":"2019-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F54-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"DCIS-Paget disease","valueDescription":"Ductal carcinoma in situ involving nipple skin (Paget disease)","ValueMeaning":{"publicId":"3211330","version":"1","preferredName":"Ductal carcinoma in situ involving nipple skin (Paget disease)","longName":"3211330","preferredDefinition":"A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (Paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast. The clinical features include focal skin reddening, and eczema. Retraction of the nipple may sometimes occur.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Paget Disease","conceptCode":"C47857","definition":"A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (Paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast. The clinical features include focal skin reddening, and eczema. Retraction of the nipple may sometimes occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EEDB-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C313FE-3F5F-4EBA-E053-4EBD850A9C0F","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"IPMN","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","ValueMeaning":{"publicId":"5611394","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","longName":"5611394","preferredDefinition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","conceptCode":"C38342","definition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E429E5-2C76-4AE2-E053-F662850A4EE8","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ALEYR","dateCreated":"2016-12-30","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-2169-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"PIN","valueDescription":"Prostatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"3250499","version":"1","preferredName":"Prostatic Intraepithelial Neoplasia","longName":"3250499","preferredDefinition":"A neoplastic proliferation of the epithelial cells that line the acini and the ducts of the prostate gland.  The neoplastic epithelial cells are confined within the acini and the ducts and they do not invade the surrounding prostatic stroma.  Morphologically, it is classified as low or high grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostatic Intraepithelial Neoplasia","conceptCode":"C4064","definition":"A neoplastic proliferation of the epithelial cells that line the acini and the ducts of the prostate gland.  The neoplastic epithelial cells are confined within the acini and the ducts and they do not invade the surrounding prostatic stroma.  Morphologically, it is classified as low or high grade.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C6B8-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-2173-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"PanIN","valueDescription":"Pancreatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"4265255","version":"1","preferredName":"Pancreatic Intraepithelial Neoplasia","longName":"4265255","preferredDefinition":"A pre-cancerous, non-invasive pancreatic epithelial neoplasm that arises from and is confined to the pancreatic ducts.  It is a papillary or flat neoplasm that usually measures less than 5 mm in diameter.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraepithelial Neoplasia","conceptCode":"C4845","definition":"A pre-cancerous, non-invasive pancreatic epithelial neoplasm that arises from and is confined to the pancreatic ducts.  It is a papillary or flat neoplasm that usually measures less than 5 mm in diameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4C43-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-217D-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"LUSC-CIS","valueDescription":"Lung Squamous Cell Carcinoma In Situ","ValueMeaning":{"publicId":"6690852","version":"1","preferredName":"Lung Squamous Cell Carcinoma In Situ","longName":"6690852","preferredDefinition":"A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma In Situ","conceptCode":"C136719","definition":"A preinvasive bronchial neoplastic lesion affecting the squamous epithelium. It is characterized by the absence of progression of maturation from base to luminal surface, basilar zone expansion with cellular crowding throughout the epithelium, absence of the intermediate zone, and surface flattening confined to the most superficial cells. The nuclear-to-cytoplasmic ratio is often high and variable, the chromatin is coarse and uneven, and mitotic figures are present through full thickness. The cell size may be markedly increased. Anisocytosis and pleomorphism may be present. (Adapted from WHO, 2015)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8657219C-EA47-1607-E053-F662850AB9A9","latestVersionIndicator":"Yes","beginDate":"2019-04-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-12","modifiedBy":"ONEDATA","dateModified":"2019-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-2187-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"LUAD-MIA","valueDescription":"Bronchioalveolar Carcinoma","ValueMeaning":{"publicId":"3106712","version":"1","preferredName":"Bronchioalveolar Carcinoma","longName":"3106712","preferredDefinition":"A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D26-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":"Updated definition to match current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-2191-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"LUAD-AIS","valueDescription":"Adenocarcinoma Solitary Lesion in situ of Lung","ValueMeaning":{"publicId":"6689895","version":"1","preferredName":"Adenocarcinoma Solitary Lesion in situ of Lung","longName":"6689895","preferredDefinition":"A solitary lesion in the lung  (less than or equal to 3 cm) with no spread through air spaces, with pure lepidic growth and no stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma Solitary Lesion in situ of Lung","conceptCode":"C158819","definition":"A solitary lesion in the lung  (less than or equal to 3 cm) with no spread through air spaces, with pure lepidic growth and no stromal, vascular, or pleural invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86433B52-8B38-10AC-E053-F662850A4C16","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-11","modifiedBy":"ONEDATA","dateModified":"2019-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-219B-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"LUAD-AAH","valueDescription":"Atypical Adenomatous Lung Hyperplasia","ValueMeaning":{"publicId":"3250153","version":"1","preferredName":"Atypical Adenomatous Lung Hyperplasia","longName":"3250153","preferredDefinition":"A multifocal neoplastic process in the lung parenchyma characterized by the proliferation of atypical alveolar epithelial cells without the presence of significant chronic inflammation.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Adenomatous Lung Hyperplasia","conceptCode":"C5665","definition":"A preinvasive lesion in the lung. It is characterized by the presence of a small, localized proliferation of mildly to moderately atypical type II pneumocytes and/or Clara cells lining alveolar walls and sometimes respiratory bronchioles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6DE8128-E908-E018-E040-BB89AD437315","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-21A5-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"DCIS","valueDescription":"Ductal Carcinoma In Situ","ValueMeaning":{"publicId":"3262799","version":"1","preferredName":"Ductal Carcinoma In Situ","longName":"3262799","preferredDefinition":"A carcinoma entirely confined to the mammary ducts.  It is also known as DCIS.  There is no evidence of invasion of the basement membrane.  Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis.  The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAB50210-A094-7298-E040-BB89AD4308A3","latestVersionIndicator":"Yes","beginDate":"2011-08-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-21AF-12BA-E053-4EBD850AEA07","beginDate":"2019-08-26","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"LUSC-Dysplasia","valueDescription":"Bronchial Intraepithelial Neoplasia","ValueMeaning":{"publicId":"3210763","version":"1","preferredName":"Bronchial Intraepithelial Neoplasia","longName":"3210763","preferredDefinition":"A term referring to neoplastic changes in the bronchial epithelium manifested as dysplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchial Intraepithelial Neoplasia","conceptCode":"C7436","definition":"A term referring to neoplastic changes in the bronchial epithelium manifested as dysplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9BC8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-21B9-12BA-E053-4EBD850AEA07","beginDate":"2019-09-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"LUSC-Metaplasia","valueDescription":"Squamous Metaplasia of Bronchial Mucosa","ValueMeaning":{"publicId":"6921679","version":"1","preferredName":"Squamous Metaplasia of Bronchial Mucosa","longName":"6921679","preferredDefinition":"Replacement of the bronchial glandular epithelial cells by squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Metaplasia of Bronchial Mucosa","conceptCode":"C80354","definition":"Replacement of the bronchial glandular epithelial cells by squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91FB11BF-7D92-40FD-E053-F662850A0B08","latestVersionIndicator":"Yes","beginDate":"2019-09-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-09-07","modifiedBy":"ONEDATA","dateModified":"2019-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-21C3-12BA-E053-4EBD850AEA07","beginDate":"2019-09-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6981B-21CD-12BA-E053-4EBD850AEA07","beginDate":"2019-10-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"Atypical ductal hyperplasia (ADH)","valueDescription":"Atypical Ductal Breast Hyperplasia","ValueMeaning":{"publicId":"3250150","version":"1","preferredName":"Atypical Ductal Breast Hyperplasia","longName":"3250150","preferredDefinition":"A benign (not cancer) condition in which there are more cells than normal in the breast lobules and the cells look abnormal under a microscope. Having atypical lobular hyperplasia increases the risk of breast cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Atypical Ductal Hyperplasia","conceptCode":"C8436","definition":"A neoplastic process that arises from the terminal ductal lobular unit of the breast parenchyma.  It is usually solitary and confined to a single lobular unit.  It is characterized by the presence of a monomorphic epithelial proliferation in a cribriform, micropapillary, or solid growth pattern.  Focal architectural features of low grade ductal carcinoma in situ are present.  There is an increased risk for development of invasive breast carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6DE8128-E8BF-E018-E040-BB89AD437315","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6B6A9-E580-6ECB-E053-4EBD850A4852","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"Usual ductal hyperplasia (UDH)","valueDescription":"Usual Ductal Breast Hyperplasia ","ValueMeaning":{"publicId":"2566467","version":"1","preferredName":"Usual Ductal Breast Hyperplasia ","longName":"2566467","preferredDefinition":"A neoplastic ductal proliferative lesion of the breast characterized by the formation of secondary lumens and prominent intraductal proliferation of a heterogeneous cellular population that may include epithelial cells, myoepithelial cells, or metaplastic apocrine cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Usual Ductal Hyperplasia","conceptCode":"C27941","definition":"A neoplastic ductal proliferative lesion of the breast characterized by the formation of secondary lumens and prominent intraductal proliferation of a heterogeneous cellular population that may include epithelial cells, myoepithelial cells, or metaplastic apocrine cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6B6A9-E58B-6ECB-E053-4EBD850A4852","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"4494160","version":"1","preferredName":"Normal","longName":"4494160","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"043C792C-06A7-5C4A-E050-BB89AD433FD8","latestVersionIndicator":"Yes","beginDate":"2014-09-29","endDate":null,"createdBy":"RODGERSC","dateCreated":"2014-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4C6B6A9-E596-6ECB-E053-4EBD850A4852","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"ONEDATA","dateModified":"2022-01-04","deletedIndicator":"No"},{"value":"HGPIN","valueDescription":"High Grade Prostatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"2581149","version":"1","preferredName":"High Grade Prostatic Intraepithelial Neoplasia","longName":"2581149","preferredDefinition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts. The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoloplasmic ratio. The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform. The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Prostatic Intraepithelial Neoplasia","conceptCode":"C5541","definition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts.  The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoplasmic ratio.  The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform.  The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DABAFBF1-C6C2-6D2C-E053-4EBD850AC741","beginDate":"2022-03-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-03-21","modifiedBy":"ONEDATA","dateModified":"2022-03-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6863671","version":"1","preferredName":"Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions Precancerous Condition Type","preferredDefinition":"A consortium consisting of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.:A pathological process with signs indicating it may become cancerous. Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia. :Something distinguishable as an identifiable class based on common qualities.","longName":"C133750:C3341:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions","conceptCode":"C133750","definition":"A consortium consisting of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Precancerous Condition","conceptCode":"C3341","definition":"A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9107759C-5661-697C-E053-F662850A2CFF","latestVersionIndicator":"Yes","beginDate":"2019-08-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4C6981B-2152-12BA-E053-4EBD850AEA07","latestVersionIndicator":"Yes","beginDate":"2022-01-04","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-01-04","modifiedBy":"COLBERTM","dateModified":"2022-03-21","changeDescription":"3/20/22mr  Added HGPIN per SME.   1/4/22 mr Versioned to 2.0 to add 13 PVs for MCL Biospecimen.  10/29/19 jk released per MCL SME (Maureen/Kristen) review. 10/25/19 jk added er Kristen Anton 10/24/19 email/review.  9/7/19 jk received/added concepts for 2 remaining PVs; chg RS to \"Application\". 8/26/19 jk created for MCL Specimen tracking system - Specimen information; waiting on terms for Meta and Dysplasia PVs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5855817","version":"1","longName":"LabCAS","context":"MCL","ClassificationSchemeItems":[{"publicId":"6944398","version":"1","longName":"MCL PCA Pilot","context":"MCL"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pre-cancer type","type":"Preferred Question Text","description":"Pre-cancer type","url":null,"context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E4FC8A-48FC-6C3B-E053-F662850A2198","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-10-14","modifiedBy":"KNABLEJ","dateModified":"2022-03-22","changeDescription":"3/22/22 jk CDE updated for versioned VD, released as part of quarterly draft content review.  10/14/19 jk created for MCL PCA genomic pilot project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}